Kynam Capital Management, LP

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1907884 PRINCETON, NJ

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$25,226,600

-$28,854,568 QoQ

Shares Held

2,522,660

-55.6% QoQ

Ownership

0.987%

of shares outstanding

% of Portfolio

1.39%

of 13F equity value

Holder Rank

#25

of 316 holders

Holding Since

Jun 2022

16 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Kynam Capital Management, LP holds $25,226,600 across 1 Drug Manufacturers - Specialty & Generic name. BCRX ranks #1 (100.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	BCRX	Biocryst Pharmaceuticals Inc This page	2,522,660	$25,226,600

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$25,226,600	2,522,660	-55.6%	Shares	Sole	2026-08-14
2026-03-31	$54,081,168	5,680,795	-39.4%	Shares	Sole	2026-05-15
2025-12-31	$73,058,902	9,366,526	-0.3%	Shares	Sole	2026-02-17
2025-09-30	$71,272,149	9,390,270	+10.9%	Shares	Sole	2025-11-14
2025-06-30	$75,835,128	8,463,742	-5.2%	Shares	Sole	2025-08-14
2025-03-31	$66,963,922	8,928,523	-1.7%	Shares	Sole	2025-05-15
2024-12-31	$68,321,967	9,085,368	0.0%	Shares	Sole	2025-02-14
2024-09-30	$69,048,796	9,085,368	+2.9%	Shares	Sole	2024-11-14
2024-06-30	$54,549,067	8,826,710	+35.2%	Shares	Sole	2024-08-14
2024-03-31	$33,159,654	6,527,491	+41.9%	Shares	Sole	2024-05-15
2023-12-31	$27,554,000	4,600,000	+46.8%	Shares	Sole	2024-02-14
2023-09-30	$22,183,006	3,133,193	+10.0%	Shares	Sole	2023-11-14
2023-06-30	$20,051,306	2,848,197	+184.8%	Shares	Sole	2023-08-14
2023-03-31	$8,340,000	1,000,000	+129.8%	Shares	Sole	2023-05-15
2022-09-30	$5,482,474	435,117	-53.5%	Shares	Sole	2022-11-14
2022-06-30	$9,908,836	936,563	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.